IMCR - חוב לטווח קצר להון Immunocore
The share price of Immunocore Holdings plc (IMCR) visualized below on the GURU.Markets platform is 0.00. The company, led by Bakhtiar Karimi, is implementing cutting-edge developments in cancer therapy. The logistics model relies on a network of global distribution centers to maintain the quality of perishable biologics. Business stability is guaranteed by a staff of leading T-cell experts and an aggressive search for specialized clinical trial professionals.
פילוחי נתונים אנליטיים מרוכזים עבור immunocore.com (IMCR)
This indicator determines the proportion of short-term borrowings relative to equity, assessing the liquidity and financial stability of the balance sheet. By analyzing the trend of short-term liabilities to equity, an investor can gauge the company's dependence on rapid refinancing, which is critically important for Immunocore Holdings plc (IMCR), given the colossal costs of multi-year clinical trials and the launch of complex TCR drug production.